Uncontrolled Hypertension
Cardiovascular·MeSH: Hypertension
Prevalence
47000.0 / 100K
Incidence
3000.0 / 100K/yr
3 drugs in development·2 companies·3 clinical trials
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| baxdrostat | ASTRAZENECA PLC (AZN) |
Phase 2(1)
| Drug | Company |
|---|---|
| cin-107 | CinCor Pharma, Inc. (CINC) |
Phase 4(1)
Compare drugs
Frequently asked questions
How many drugs are in development for Uncontrolled Hypertension?
BioSniper tracks 3 drugs in development for Uncontrolled Hypertension across 2 companies.
How many clinical trials target Uncontrolled Hypertension?
There are 3 clinical trials targeting Uncontrolled Hypertension tracked by BioSniper.
What is the prevalence of Uncontrolled Hypertension?
The estimated prevalence of Uncontrolled Hypertension is approximately 47000.0 per 100,000 population.
Deep-dive into Uncontrolled Hypertension
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis